India's Health Ministry has mooted that either the Centre or state authorities be empowered to regulate the manufacture of drugs and cosmet...

The CDSCO and Ministry of Health have taken regulatory measures to ensure the quality of medicines in the country as part of which the Drug...

A committee of two joint drugs controllers has been constituted at the CDSCO headquarters to monitor the process of inspection, reporting a...

The government is planning an overhaul of the country’s drug regulatory body. Towards this, the committee has recommended introduction of c...

The law provides for penal actions ranging from monetary fine to imprisonment for sale of such "unapproved" products.

"The United States Food and Drug Administration (USFDA) has conducted an inspection at our sterile injectable site (CP-IV) located at Gummu...

The government to check spurious and sub-standard drugs in the country has amended the Drugs and Cosmetics Act, 1940.

"Track and Trace software has been developed for authentication of drugs manufactured in India," Health Minister J P Nadda said.

Repeated violators of provisions with regard to clinical trials under new Drug and Cosmetics (Amendment) Bill, 2015 will attract imprisonme...

Shares of Ipca Laboratories today fell sharply by 13 per cent as the company voluntarily stopped active pharmaceutical ingredients (API) sh...

The government today said it has ordered the Drug Controller General of India (DCGI) to check the quality of drugs produced by Ranbaxy Labo...

FDA said that their several products have been found to be "adulterated" under relevant regulations and did not carry the required permits ...

Ranbaxy facilities in India are being reviewed after its US arm admitted to manufacturing certain drugs not in conformity with good practic...

The today agreed to hear next week a PIL seeking cancellation of license granted to Ranbaxy Laboratories.

An advocate today approached the Supreme Court with a PIL seeking cancellation of the license granted to Ranbaxy Laboratories Ltd and for i...

Ambiguity in terms such as 'adulterated' & 'spurious' may complicate patent challenge & regulation of firms

The government on Friday said the Amendment bill suggesting death penalty for spurious drug manufacturers would be taken up by the Cabinet